Perspectives of Molecularly Imprinted Polymer-Based Drug Delivery Systems in Cancer Therapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Oncology

Background:

• Conventional chemotherapy faces challenges including severe toxicity, poor bioavailability, and multidrug resistance.
• There is a need for advanced drug delivery systems for efficient, localized, and controlled delivery of anticancer agents.
• Molecular imprinting offers a promising approach for developing tailored drug carriers.

Purpose of the Study:

• To review the current state-of-the-art of molecularly imprinted polymer (MIP)-based drug delivery systems for anticancer therapy.
• To highlight the specific characteristics of chemotherapeutic release from MIPs.
• To critically assess the challenges and future perspectives of MIP drug carriers.

Main Methods:

• Literature review focusing on molecular imprinting techniques for drug delivery.
• Analysis of studies detailing the design and performance of MIPs for cancer treatment.
• Evaluation of data on drug loading, release kinetics, and in vitro/in vivo efficacy.
• Assessment of challenges related to specificity, scalability, and clinical translation.

Main Results:

• MIPs provide specific and selective binding sites for chemotherapeutic agents.
• These systems demonstrate tunable features, including high drug loading capacity and controlled release profiles.
• MIPs show potential for localized and dose-controlled delivery, mitigating systemic toxicity.
• Various MIP designs have been explored for different anticancer drugs.

Conclusions:

• Molecularly imprinted polymers represent a promising platform for developing next-generation anticancer drug delivery systems.
• Further research is needed to address current challenges and optimize MIPs for clinical application.
• MIPs offer a pathway to enhance the efficacy and safety of cancer chemotherapy.